'' '' '' ''
![]() |
PRINT ISSN : 2319-7692 Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Hospital acquired infections (HAIs) are the commonest untoward incident in healthcare delivery worldwide that not only bring additional medical cost but also, extend hospital stay and affect patient’s morbidity and mortality. Urinary tract infections (UTIs) account for majority of these infections. The objective is to estimate hospital acquired UTIs prevalence and antibiogram among the admitted cancer patients. Also, to evaluate the performance of chromogenic Uriselect 4 agar medium in isolation and presumptive identification of nosocomial UTIs. Among 10414 patients stayed in hospital > 48 h., 1080patients were suspected to have nosocomial UTIs. 698 (64.6 %) were catheterized and 382 (35.4%) were not. (4.49%) patients confirmed to have nosocomial UTIs. 468 (43.3%) yielded aerobic growth on CLED agar, versus 624(57.8%) on the chromogenic Uriselect4 media. On CLED, 408 isolates were identified by automated Vitek 2 system versus 348 (33.3%) were identified by manual biochemical reactions while 10% and 1.7% of the isolates were not identified by manual biochemical tests and automated Vitek2 system respectively. E.coli was the most frequent isolated uropathogen in cancer patients identified by manual biochemical reactions, automated Vitek 2 system and chromogenic Uriselect 4 medium(11.1%, 23.1% and 17.8% respectively).Catheterization had been the main risk factor for nosocomial infection in our patients.
![]() |
![]() |
![]() |
![]() |
![]() |